Campaigner Jayne on her legacy and life after cancer WalesOnline, United Kingdom - She took a leading role in the fight for men with prostate cancer to receive low-dose brachytherapy ? the campaign was ultimately successful. ...
The finish line Napa Valley Register, CA - Nov 30, 2008 If there were ever a time to go slow, this is it, she said. There?s always next year. And then there was Jenny. Anticipating that her father, the cancer...
Movember helps erase stiff upper lip on men's health The Canberra Times, Australia - Nov 29, 2008 They researched men's health issues and found two they felt deserved greater exposure: prostate cancer and depression. Slattery says the moustache provided ...
Men have mo fun with this month's fund-raiser Peterborough Today, UK - Nov 28, 2008 John said: "I think in the majority of cases, prostate cancer is slow-growing so if it's detected early, there is the option to do something about it. ...
Local men facing prostate cancer lean on one another Monroenews.com, MI - Nov 16, 2008 He said prostate cancer usually consists of a slow-growing tumor and patients need to watch its growth. "Once it becomes more active, you may need surgery ...
Doctors rethink treatment for prostate cancer in older men Lower Hudson Journal news, NY - Nov 6, 2008 Because prostate cancer is generally a slow-growing cancer, some men may never need treatment. And for many older men without symptoms, watchful waiting has ...
Source: Google News
Recent News and Articles on the Keywords: prostate + growth + cancer Related to the article below (Last Update: 8/7/2008)
Delay in body growth linked to prostate cancer Reuters - Aug 5, 2008 "The study has underlined the potential effect of the 'timing' at exposure of sexual and (body growth) variables on the risk of prostate cancer," senior ...
Researchers Identify Promising Prostate Cancer Drug Target eMaxHealth.com, NC - Mutations that inactivate PTEN ? in effect releasing the brake on growth signals ? are found in a significant proportion of prostate, breast and brain ...
Hollis-Eden Pharmaceuticals Reports on Progress in Drug ... Business Wire (press release), CA - Hollis-Eden has commenced a Phase I/II clinical trial with its oral drug candidate APOPTONE? (HE3235) in late-stage prostate cancer patients who have failed ...HEPH
Clarient Reports Second Quarter Revenue Up 71% MarketWatch - ... Dx Breast Cancer Profile in the second half of 2008, and with the progress we are making in the development of our breast and prostate cancer programs, ...
European payers question value of new cancer drugs guardian.co.uk, UK - But that buoyant growth is forecast to drop below 10 percent by the end of the period, reflecting growing financial constraints on payers and increased ...
Now our patients lose cancer clinic The Canberra Times, Australia - Canberra has the highest rates of breast and prostate cancer in the country, according to figures from the Australian Institute of Health and Welfare. ...
Increasing the ratio of omega-3 to omega-6 fatty acids in the diet appears to slow the progression of prostate cancer, according to the results of an animal study.
The so-called Western diet commonly consumed in the US contains mostly omega-6 fatty acids, derived from corn oil and other sources. Omega-3 fatty acids, by contrast, are abundant in cold-water fish, a food source missing in the diets of many Americans.
"Our study showed that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decreasing the amount of omega-6 fatty acids reduced prostate cancer tumor growth rates and PSA levels in mice," senior author Dr. William J. Aronson, from the University of California, Los Angeles School of Medicine, told Reuters Health.
Aronson noted that the Western diet usually contains an omega-6 to -3 ratio of about 15 to 1. In the current study, comparison animals received a diet containing a similar ratio, while intervention animals were given a diet with a ratio of about 1 to 1.
Aronson believes that with dietary changes and the use of fish oil supplements, an omega-6 to -3 ratio of 2 to 1 or possibly lower is attainable in prostate cancer patients.
The new study, reported in Clinical Cancer Research, involved mice implanted with human prostate cancer cells. Aside from the difference in the omega-6 to -3 ratio, all of the animals received identical 20 percent fat diets.
Tumor growth rates, the final tumor size, and PSA levels were all lower in the intervention group compared with mice given Western diets. Laboratory testing showed that cancer cells grew 22 percent slower in culture dishes containing body fluid from the intervention group. Consumption of the increased omega-3 diet was also associated with an 83% reduction in tumor prostaglandin E (PGE)-2 levels, a chemical known to promote inflammation.
"This is an initial animal-model study that is one of the first to show the impact of diet on lowering an inflammatory response known to promote prostate tumor progression in tumors. More research needs to be done before clinical recommendations can be made, but the finding is significant," Aronson noted.
"At this point we would not recommend changing fatty acid intake for prostate cancer patients. However, we are conducting a randomized study in men to test if dietary changes affect prostate tissue levels of COX-2 and PGE-2," he added.
